Ria Advisory Group LLC Bristol Myers Squibb CO Transaction History

Ria Advisory Group LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 31, 2024	SELL	$48.48 - $57.85 $34,226 - $40,842	-706 Reduced 7.72%	8,436 $433 Million
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $39,075 - $43,692	-675 Reduced 6.88%	9,142 $531 Million
Q2 2023 Jul 25, 2023	BUY	$63.71 - $70.74 $198,966 - $220,921	3,123 Added 46.65%	9,817 $628 Million
Q1 2023 Apr 25, 2023	SELL	$65.71 - $74.53 $7,753 - $8,794	-118 Reduced 1.73%	6,694 $464 Million
Q4 2022 Feb 09, 2023	BUY	$68.48 - $81.09 $466,485 - $552,385	6,812 New	6,812 $490 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Ria Advisory Group LLC, based on Form 13F filings with the SEC.

Stay updated on Ria Advisory Group LLC with notifications on news.